Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew T. Roe, MD, MHS
Duke Clinical Research Institute
Principal Investigator - Michael Gibson, MD, MS
PERFUSE Angiographic Core Laboratory and Data Coordinating Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Foothills Hospital
Calgary, Alberta, Canada
- Royal Alexandria Hospital
Edmonton, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- St. Paul'S Hospital
Vancouver, British Columbia, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Victoria Heart Institute, Royal Jubilee Hospital
Victoria, British Columbia, Canada
- Atlantic Health Services
Saint John, New Brunswick, Canada
- General Hospital - Heath Sciences Centre
St. John's, Newfoundland and Labrador, Canada
- Queen Elizabeth Ii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Hamilton Health Sciences
Hamilton, Ontario, Canada
- London Health Sciences
London, Ontario, Canada
- Trillium Health Centre - Mississaugua
Mississauga, Ontario, Canada
- Soutlake Regional Health Centre
Newmarket, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire de Montreal - Hotel Dieu
Montreal, Quebec, Canada
- Hospital Du Sacre Coeur
Montreal, Quebec, Canada
- Montreal Heart Institute
Montreal, Quebec, Canada
- Regina General Hospital
Regina, Saskatchewan, Canada
- Tallahassee Memorial Medical Center
Tallahassee, Florida, United States
- Iowa Heart Center
Des Moines, Iowa, United States
- University of Kentucky Hospital, Gill Heart Center
Lexington, Kentucky, United States
- Maine Medical Center
Portland, Maine, United States
- Washington Adventist Hospital
Takoma Park, Maryland, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Genesys Regional Medical Center
Grand Blanc, Michigan, United States
- St. Joseph Mercy - Oakland
Pontiac, Michigan, United States
- William Beaumont Hospital
Royal Oak, Michigan, United States
- William Beaumont Hospital - Troy Cardiology
Troy, Michigan, United States
- Lindner Clinical Trial Center
Cincinnati, Ohio, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- the Heart Center
Kingsport, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 31 Jul 2008
- Completion
- 31 Jul 2008
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 70
- Registry id
- NCT00546260
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.